Your browser doesn't support javascript.
loading
The intrinsically disordered CARDs-Helicase linker in RIG-I is a molecular gate for RNA proofreading.
Schweibenz, Brandon D; Devarkar, Swapnil C; Solotchi, Mihai; Craig, Candice; Zheng, Jie; Pascal, Bruce D; Gokhale, Samantha; Xie, Ping; Griffin, Patrick R; Patel, Smita S.
Afiliação
  • Schweibenz BD; Department of Biochemistry and Molecular Biology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, USA.
  • Devarkar SC; Graduate Program in Biochemistry, Rutgers University, Piscataway, NJ, USA.
  • Solotchi M; Department of Biochemistry and Molecular Biology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, USA.
  • Craig C; Graduate Program in Biochemistry, Rutgers University, Piscataway, NJ, USA.
  • Zheng J; Department of Biochemistry and Molecular Biology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, USA.
  • Pascal BD; Cell and Development Biology, Rutgers University, Piscataway, NJ, USA.
  • Gokhale S; Department of Biochemistry and Molecular Biology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, USA.
  • Xie P; Graduate Program in Biochemistry, Rutgers University, Piscataway, NJ, USA.
  • Griffin PR; Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL, USA.
  • Patel SS; Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL, USA.
EMBO J ; 41(10): e109782, 2022 05 16.
Article em En | MEDLINE | ID: mdl-35437807
The innate immune receptor RIG-I provides a first line of defense against viral infections. Viral RNAs are recognized by RIG-I's C-terminal domain (CTD), but the RNA must engage the helicase domain to release the signaling CARD (Caspase Activation and Recruitment Domain) domains from their autoinhibitory CARD2:Hel2i interactions. Because the helicase itself lacks RNA specificity, mechanisms to proofread RNAs entering the helicase domain must exist. Although such mechanisms would be crucial in preventing aberrant immune responses by non-specific RNAs, they remain largely uncharacterized to date. This study reveals a previously unknown proofreading mechanism through which RIG-I ensures that the helicase engages RNAs explicitly recognized by the CTD. A crucial part of this mechanism involves the intrinsically disordered CARDs-Helicase Linker (CHL), which connects the CARDs to the helicase subdomain Hel1. CHL uses its negatively charged regions to antagonize incoming RNAs electrostatically. In addition to this RNA gating function, CHL is essential for stabilization of the CARD2:Hel2i interface. Overall, we uncover that the CHL and CARD2:Hel2i interface work together to establish a tunable gating mechanism that allows CTD-chosen RNAs to bind the helicase domain, while at the same time blocking non-specific RNAs. These findings also indicate that CHL could represent a novel target for RIG-I-based therapeutics.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA de Cadeia Dupla / RNA Helicases DEAD-box Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA de Cadeia Dupla / RNA Helicases DEAD-box Idioma: En Ano de publicação: 2022 Tipo de documento: Article